GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study.

Mayo Clin Proc · 2020 · PMC7470718 · PMID 33153629

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

did not reach statistical significanceP =.06so close (0.05 < p ≤ 0.1)

Ventilator-free survival was better in the lenzilumab cohort compared with the untreated group, but did not reach statistical significance (x 2 =3.67, P =.06) ( Figure 1 B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.